These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8428077)

  • 1. Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent.
    Unger EC; Fritz TA; Palestrant D; Meakem TJ; Granstrom P; Gatenby RA
    J Magn Reson Imaging; 1993; 3(1):119-24. PubMed ID: 8428077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL; Muller HH; Young SW
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric gastrointestinal MR contrast agents.
    Tilcock C; Unger EC; Ahkong QF; Fritz T; Koenig SH; Brown RD
    J Magn Reson Imaging; 1991; 1(4):463-7. PubMed ID: 1790369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.
    Hahn PF; Stark DD; Lewis JM; Saini S; Elizondo G; Weissleder R; Fretz CJ; Ferrucci JT
    Radiology; 1990 Jun; 175(3):695-700. PubMed ID: 2343116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study.
    Lönnemark M; Hemmingsson A; Bach-Gansmo T; Ericsson A; Oksendal A; Nyman R; Moxnes A
    Acta Radiol; 1989; 30(2):193-6. PubMed ID: 2923745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions.
    Wesbey GE; Brasch RC; Engelstad BL; Moss AA; Crooks LE; Brito AC
    Radiology; 1983 Oct; 149(1):175-80. PubMed ID: 6611926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.
    Wesbey GE; Brasch RC; Goldberg HI; Engelstad BL; Moss AA
    Magn Reson Imaging; 1985; 3(1):57-64. PubMed ID: 3923293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivo.
    Rubin DL; Muller HH; Sidhu MK; Young SW; Hunke WA; Gorman WG
    J Magn Reson Imaging; 1993; 3(1):113-8. PubMed ID: 8428076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
    Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
    Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
    Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative gastrointestinal contrast enhancement and image distortion induced by superparamagnetic particles at 0.02 Tesla.
    Niemi P; Paajanen H; Hals PA; Tertti M; Komu M; Kormano M
    Magn Reson Imaging; 1989; 7(6):649-53. PubMed ID: 2630848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.
    Boehm-Sturm P; Haeckel A; Hauptmann R; Mueller S; Kuhl CK; Schellenberger EA
    Radiology; 2018 Feb; 286(2):537-546. PubMed ID: 28880786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
    Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
    Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dietary phytate on faecal absorption of radioactive ferric chloride.
    FOY H; KONDI A; AUSTIN WH
    Nature; 1959 Mar; 183(4662):691-2. PubMed ID: 13632842
    [No Abstract]   [Full Text] [Related]  

  • 17. MR imaging of the gastrointestinal tract: value of Gd-DTPA.
    Laniado M; Kornmesser W; Hamm B; Clauss W; Weinmann HJ; Felix R
    AJR Am J Roentgenol; 1988 Apr; 150(4):817-21. PubMed ID: 3126628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of experimental inflammatory bowel disease: quantitative and qualitative analyses with histopathologic correlation in a rat model using the ultrasmall iron oxide SHU 555 C.
    Frericks BB; Wacker F; Loddenkemper C; Valdeig S; Hotz B; Wolf KJ; Misselwitz B; Kühl A; Hoffmann JC
    Invest Radiol; 2009 Jan; 44(1):23-30. PubMed ID: 18836385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly effective, nontoxic T1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles.
    Tromsdorf UI; Bruns OT; Salmen SC; Beisiegel U; Weller H
    Nano Lett; 2009 Dec; 9(12):4434-40. PubMed ID: 19799448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen.
    Malcolm PN; Brown JJ; Hahn PF; Stillman AE; Li KC; Kawamura Y; Tanaka T; Noel JK; Molony BA; Johnson MF; Hildebolt CF
    J Magn Reson Imaging; 2000 Nov; 12(5):702-7. PubMed ID: 11050639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.